Valneva must immediately cease U.S. shipments and sales of Ixchiq, a vaccine for chikungunya virus. The FDA recently lifted a ...

According to the vaccine's maker, Valneva, the FDA based its decision to suspend the shot on four new serious adverse events ...

The FDA announced it has commenced daily publication of adverse event data from the FDA Adverse Event Reporting System (FAERS ...

As Department of Health and Human Services (HHS) and FDA leadership continue to look for ways to boost transparency and ...

The FDA said it has begun publishing reports of adverse events concerning drugs on a daily basis, instead of quarterly, as it ...

The FDA will now publish adverse event data from FAERS on a daily basis, marking a major step toward greater transparency in drug development.

The U.S. Food and Drug Administration (USFDA) has suspended the biologics license of Ixchiq (Chikungunya Vaccine, Live), ...

The FDA Adverse Event Reporting System, which Commissioner Marty Makary called “clunky,” previously published updates on a ...

The U.S. Food and Drug Administration has started "real-time reporting of adverse event data," according to an annoucement ...

The U.S. Food and Drug Administration said that it has begun the daily publication of adverse event reports related to drugs ...

The FDA has started reporting real-time data about adverse events through the FDA Adverse Event Reporting System, improving ...

A new commission will investigate the prevalence of SSRI antidepressants as adverse event reports document hundreds of cases ...